GLP-1 receptor agonists are the most effective weight-management medications ever brought to market. They are also not universally suitable — some patients have contraindications, some cannot tolerate the gastrointestinal effects, some do not meet the clinical criteria, and a great many simply cannot afford them.
Being outside that group is not the end of medical weight management. This guide covers what genuinely exists as an alternative, ranked honestly by evidence — and is equally direct about the large category of things marketed as ’natural Ozempic’ that are not alternatives at all.
First: Are You Actually Ruled Out?
Before pursuing alternatives, check whether the barrier is real or solvable. If cost is the obstacle, compounded providers start around $99 a month and brand-name orals around $149 — see our cheapest provider guide. If side effects are the obstacle, a lower starting dose and slower titration resolve it for many patients. If injections are the obstacle, two oral GLP-1s now exist.
Genuine exclusions — a personal or family history of medullary thyroid carcinoma, MEN 2, pregnancy — are a different matter, and this guide is for you.
Other FDA-Approved Weight Management Medications
Several medications are FDA-approved for chronic weight management through mechanisms other than the newer dual and single GLP-1 agonists. They generally produce less weight loss, but they are real medicines with real evidence, and some suit patients the newer drugs do not.
Liraglutide (Saxenda)
An older once-daily GLP-1, approved for chronic weight management. It generally produces less weight loss than semaglutide or tirzepatide and requires daily rather than weekly injection — but it remains a legitimate option, and Hers’s own patient education notes the monthly cost is often more affordable than tirzepatide. Notably, Levity is one of very few telehealth providers still offering it.
Non-GLP-1 Oral Medications
Several oral medications are FDA-approved for chronic weight management through appetite and metabolic pathways unrelated to GLP-1 signalling. Coverage from GoodRx and others lists options including phentermine-topiramate, naltrexone-bupropion, orlistat and phentermine among alternatives to consider when a GLP-1 cannot be filled or is unsuitable.
Where to Get These
Found offers non-GLP-1 plan options starting at $49 per month, which is materially cheaper than any GLP-1 route and is designed for exactly this situation.
Form Health’s board-certified obesity medicine physicians prescribe across the full range of approved anti-obesity pharmacotherapy rather than GLP-1s alone — the right setting for a genuinely individualised decision.
Which of these suits you is a clinical question involving your comorbidities, other medications and history. This is not a menu to choose from yourself.
Metabolic and Bariatric Surgery
For patients meeting surgical criteria, metabolic and bariatric surgery remains the most effective and most durable intervention available for obesity — more so than any medication, including tirzepatide.
It is also a major operation with surgical risk, a recovery period, permanent anatomical change and lifelong nutritional follow-up requirements. Trimi’s own patient content notes gastric bypass typically costs $15,000 to $25,000, carries surgical risks, requires weeks of recovery and involves permanent changes to the digestive system — a fair summary of the trade-off.
Surgery and GLP-1 therapy are not mutually exclusive. Some patients use medication before surgery, some after, and some as an alternative. A referral to a bariatric surgical program is a reasonable step to discuss with an obesity medicine specialist if your BMI and comorbidity profile put you in range.
The Honest Section: Supplements and ’Natural Ozempic’
This Category Is Mostly Marketing
Search results for GLP-1 alternatives are saturated with berberine, fibre supplements, and products positioned as ’natural Ozempic’ or over-the-counter equivalents.
There is no over-the-counter supplement that is equivalent to a GLP-1 receptor agonist. Semaglutide produces roughly 15% weight loss and tirzepatide over 20% in clinical trials. No supplement has evidence anywhere near that, and the products marketed this way are generally sold by companies with a commercial interest in the comparison.
That is not to say nothing in this space has any effect. Some fibre supplements modestly increase satiety. Some agents have limited evidence for small metabolic effects. But the framing matters enormously: these are not substitutes for pharmacotherapy, and a patient who genuinely needs medical weight management is poorly served by being pointed at them.
We have now reviewed this category in detail — see our evidence review of GLP-1 supplements, our individual supplement reviews, and the safety and interactions guide. Be particularly cautious with anything sold as a research chemical. The FDA has published concerns about unapproved GLP-1 drugs used for weight loss, including instances of telehealth companies marketing unapproved compounds such as retatrutide directly to consumers. Anything labelled ’for research purposes only’ is not a bargain — it is an unapproved drug with no safety assurance whatsoever.
Lifestyle Intervention, Properly Resourced
This deserves better treatment than the dismissive mention it usually receives. Structured, professionally supported lifestyle intervention produces real if generally more modest weight loss, and it is the foundation every medication is prescribed alongside — GLP-1 labelling specifies use with a reduced-calorie diet and increased physical activity.
The distinction that matters is resourced versus unresourced. ’Eat less, move more’ as advice is close to useless. Working with a registered dietitian on protein targets and meal structure, plus a resistance training programme, is a genuine clinical intervention.
- Medical nutrition therapy is covered by many insurance plans when tied to a diagnosis such as obesity or diabetes — a commonly overlooked benefit worth checking.
- Resistance training protects lean mass, which matters whether or not you are on medication.
- Behavioural programmes such as those offered by Noom and WeightWatchers have long track records independent of GLP-1 prescribing.
- Sleep and stress both affect appetite regulation and are addressed in structured programmes such as Calibrate’s curriculum.
If Cost Is the Only Barrier
This is worth separating out, because a patient who could take a GLP-1 but cannot afford one has options that a patient with a genuine contraindication does not.
| Route | Approximate Cost | Notes |
|---|---|---|
| Flat-rate compounded providers | From $99/month all-in | See compounded provider guide |
| Brand-name oral GLP-1s | From $149/month self-pay | Wegovy tablet via NovoCare; Foundayo from $25 for eligible patients |
| Insurance coverage | As low as $25/month copay | See insurance provider guide |
| Employer-sponsored programmes | Frequently $0 for care | Teladoc, 9amHealth, knownwell and Form Health distribute this way |
| Medicare pathways | $50/month medication | Sesame and the Walgreens Medicare GLP-1 Bridge |
| Non-GLP-1 medications | From $49/month | Found’s non-GLP-1 plans |
Also use pre-tax dollars. Prescription costs are generally HSA and FSA eligible, which effectively discounts your spend by your marginal tax rate — for many households 22% to 32%. See our insurance and HSA/FSA guide.
The Bottom Line
First, check whether you are genuinely ruled out. Cost, side effects and needle aversion are all solvable — compounded providers start at $99, slower titration fixes tolerability for many, and two oral GLP-1s now exist.
If you are genuinely excluded, real alternatives exist. Other FDA-approved anti-obesity medications work through different mechanisms, liraglutide remains an option, and for patients meeting surgical criteria, metabolic and bariatric surgery is more effective and more durable than any medication.
Supplements marketed as ’natural Ozempic’ are not alternatives. No over-the-counter product approaches GLP-1 efficacy, and anything sold ’for research purposes only’ is an unapproved drug the FDA has warned about — not a cheaper version of the same thing.
The right next step is an obesity medicine consultation, not a self-directed search. Form Health’s board-certified specialists prescribe across the full pharmacotherapy range and accept Medicare, and Found offers non-GLP-1 plans from $49 a month.
Frequently Asked Questions
What is the best alternative to Ozempic?
It depends on why Ozempic is not suitable. If cost is the issue, compounded semaglutide or a brand-name oral GLP-1 at $149 a month may work. If you have a contraindication, other FDA-approved anti-obesity medications working through different mechanisms are the appropriate route. If you meet surgical criteria, bariatric surgery is more effective than any medication. Only a clinician can determine which applies to you.
Is there a natural or over-the-counter alternative to Wegovy?
No. There is no over-the-counter supplement equivalent to a GLP-1 receptor agonist. Semaglutide produces roughly 15% weight loss in trials and tirzepatide over 20%; no supplement has evidence remotely comparable. Products marketed as ’natural Ozempic’ are marketing rather than medicine.
What about berberine?
Berberine is widely marketed as a natural GLP-1 alternative. The evidence does not support treating it as equivalent to GLP-1 pharmacotherapy, and the comparison is generally made by parties selling it. If you are considering it, discuss it with your clinician alongside your other medications rather than as a substitute for treatment.
Is Saxenda still a reasonable option?
Yes for some patients. Liraglutide is an older once-daily GLP-1 approved for chronic weight management. It generally produces less weight loss than semaglutide or tirzepatide and requires daily injection, but it remains a legitimate medicine. Very few telehealth platforms still offer it — Levity is one that does.
Should I consider bariatric surgery instead?
For patients meeting surgical criteria, metabolic and bariatric surgery remains the most effective and durable intervention for obesity — more effective than any medication. It is also a major operation with real risks, a recovery period, permanent anatomical change and lifelong nutritional follow-up. Discuss it with an obesity medicine specialist.
What if I cannot tolerate the side effects?
Before abandoning GLP-1s entirely, discuss a lower starting dose and slower titration with your clinician. Providers such as Alloy explicitly offer personalised dosing for gentler starts. A meaningful share of patients who discontinue for gastrointestinal reasons could have continued on a gentler schedule.
Are non-GLP-1 weight loss medications much less effective?
Generally they produce less weight loss than semaglutide or tirzepatide, though results vary by medication and individual. That does not make them ineffective — for a patient who cannot take a GLP-1, a medication producing meaningful loss is considerably better than no pharmacotherapy at all.
What is retatrutide and should I try it?
Retatrutide is an investigational compound. The FDA has published concerns about unapproved GLP-1 drugs used for weight loss, including telehealth companies marketing unapproved compounds such as retatrutide directly to consumers. It is not an approved medication and should not be obtained through consumer channels.
⚕️ Medical Disclaimer:
This article is for informational purposes only and is not medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with serious risks and contraindications, including a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. See our full medical disclaimer.
Disclosure:
This article is based on publicly available information including FDA public communications, manufacturer and provider materials, and general clinical understanding of approved weight management pharmacotherapy, current as of August 2026. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews. Descriptions of medication categories are general and not exhaustive; approved indications, contraindications and comparative efficacy vary by product and should be reviewed with a clinician using the FDA-approved prescribing information. Statements about supplements reflect the absence of evidence supporting equivalence to GLP-1 pharmacotherapy and are not a comprehensive assessment of any individual product. Nothing here is medical advice — decisions about weight management treatment must be made with a licensed clinician who knows your full history.
Related Reading
Best Non-GLP-1 Weight Loss Medications
Qsymia, Contrave and the approved oral options, compared on efficacy and real cost.
Do You Qualify for a GLP-1?
The clinical criteria, contraindications and what to do if you do not qualify.
Managing GLP-1 Side Effects
Strategies that keep many patients on treatment who would otherwise stop.
Cheapest GLP-1 Providers
If cost is the only barrier, start here before seeking alternatives.
Best Providers That Take Insurance
Where coverage actually works, including Medicare pathways.